Download presentation
Presentation is loading. Please wait.
Published bySurya Gunawan Modified over 5 years ago
1
Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes
Anick Bérard, MSc, PhD, Odile Sheehy, MSc, Marie-Laure Kurzinger, MSc, Juhaeri Juhaeri, PhD Journal of Allergy and Clinical Immunology Volume 138, Issue 1, Pages e7 (July 2016) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig E1 Study population selection. INCS, Intranasal corticosteroids; MCM, major congenital malformation. Journal of Allergy and Clinical Immunology , e7DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig E2 Prevalence of major congenital malformation, respiratory system malformations, and pregnancies exposed to triamcinolone or other intranasal corticosteroids per year of conception. Journal of Allergy and Clinical Immunology , e7DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.